NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter
Press Release
Read More
Clinical utility of TP53 mutations (TP53m) dynamic monitoring in circulating tumor DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)
Literature
Read More
NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China
Press Release
Read More
NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020
Press Release
Read More
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
Literature
Read More
Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types
Literature
Read More